SLC25A23 Antibody

What is SLC25A23 and what is its primary function in cellular physiology?

SLC25A23 is a mitochondrial carrier protein that functions as an electroneutral antiporter mediating the transport of adenine nucleotides across the inner mitochondrial membrane. Originally identified as an ATP-magnesium/inorganic phosphate antiporter, it also acts as a broad specificity adenyl nucleotide antiporter. Through regulation of the mitochondrial matrix adenine nucleotide pool, SLC25A23 adapts to changing cellular energetic demands and indirectly regulates adenine nucleotide-dependent metabolic pathways . More significantly, it serves as a critical regulator of mitochondrial calcium uptake and can transport trace amounts of other divalent metal cations in complex with ATP .

What types of SLC25A23 antibodies are currently available for research?

Several types of SLC25A23 antibodies have been developed for research applications. These include:

• Rabbit polyclonal antibodies targeting the C-terminal region (aa 300 to C-terminus) of human SLC25A23, suitable for Western blotting applications with human samples

• Mouse monoclonal antibodies (clone 3E1, isotype IgG2a) targeting the N-terminal region (aa 2-74) of SLC25A23, applicable for ELISA and Western blotting with human samples

• Additional polyclonal antibodies with varying immunogen specifications and applications including immunofluorescence (IF)

Each antibody has specific applications and reactivity profiles based on the epitope targeted and the host species used for production.

What are the alternative names for SLC25A23 that researchers should be aware of?

When searching literature and reagents for SLC25A23, researchers should be aware of several alternative nomenclature designations including:

• APC2 (ATP-Mg/Pi Carrier 2)

• MCSC2 (Mitochondrial Calcium-Sensitive Carrier 2)

• SCAMC3 (Short Calcium-binding Mitochondrial Carrier 3)

• Mitochondrial adenyl nucleotide antiporter SLC25A23

• Mitochondrial ATP-Mg/Pi carrier protein 2

• Solute carrier family 25 member 23

Using these alternative designations during literature searches ensures comprehensive coverage of relevant research.

What are the validated applications for SLC25A23 antibodies in research protocols?

SLC25A23 antibodies have been validated for several experimental applications:

• Western Blotting (WB): Both polyclonal and monoclonal antibodies have demonstrated efficacy in detecting SLC25A23 protein in denatured samples

• Enzyme-Linked Immunosorbent Assay (ELISA): Monoclonal antibodies specific to amino acids 2-74 have shown utility in quantitative detection

• Immunofluorescence (IF): Select polyclonal antibodies have been validated for localization studies of SLC25A23 in fixed cells

Researchers should confirm the specific application validations for their selected antibody, as reactivity varies between products and experimental conditions.

What protocols should be optimized when using SLC25A23 antibodies for Western blotting?

When utilizing SLC25A23 antibodies for Western blotting, researchers should consider the following optimization steps:

• Sample preparation: Ensure complete lysis of mitochondrial membranes using appropriate detergents

• Protein loading: 20-50μg of total protein is typically sufficient for detection

• Transfer conditions: Optimize for the size of SLC25A23 (approximately 52-55 kDa)

• Blocking: Use 5% non-fat milk or BSA in TBST buffer

• Primary antibody dilution: Typically 1:500-1:2000 depending on the specific antibody

• Secondary antibody selection: Match to the host species (rabbit or mouse depending on primary antibody)

• Detection method: Both chemiluminescence and fluorescence-based methods can be effective

These parameters may require experimental adjustment based on cell/tissue type and expression levels of SLC25A23.

How can researchers effectively knockdown SLC25A23 for functional studies?

For SLC25A23 knockdown studies, researchers have successfully employed lentiviral shRNA approaches. Based on published methodologies:

• Design sequence-specific shRNAs targeting SLC25A23 mRNA (clone #864 has demonstrated specificity and efficacy)

• Generate lentiviral particles containing the shRNA constructs

• Transduce target cells and select with appropriate antibiotic (e.g., puromycin)

• Validate knockdown efficiency using quantitative real-time PCR (qRT-PCR) and Western blotting

• Establish stable cell lines from single-cell colonies for consistent knockdown

When designing knockdown experiments, it's crucial to verify specificity by confirming that related family members (SLC25A24 and SLC25A25) remain unaffected . This ensures that observed phenotypes are specifically attributable to SLC25A23 depletion rather than off-target effects.

How does SLC25A23 interact with the mitochondrial calcium uniporter complex, and how can these interactions be studied?

SLC25A23 has been demonstrated to interact with key components of the mitochondrial calcium uniporter complex, including MCU (mitochondrial calcium uniporter) and MICU1 (mitochondrial calcium uptake 1). These interactions can be studied through:

• Co-immunoprecipitation: Using tagged versions of SLC25A23 (Flag-tagged), MCU (GFP-tagged), and MICU1 (HA-tagged), researchers have successfully demonstrated physical interactions between these proteins

• Functional studies: Mitoplast patch clamping has revealed that SLC25A23 knockdown reduces MCU current (IMCU) in conditions with and without phosphate supplementation

• Calcium imaging: Using both chemical indicators (Rhod-2 AM) and genetic reporters (GCaMP2-mt) to assess mitochondrial calcium dynamics following SLC25A23 manipulation

These approaches have collectively established that SLC25A23 enhances MCU activity through direct protein-protein interactions, rather than merely through its canonical role as a phosphate carrier.

What techniques can be used to assess the impact of SLC25A23 on mitochondrial calcium dynamics?

Several complementary techniques can assess SLC25A23's role in mitochondrial calcium handling:

• Chemical calcium indicators:

  • Rhod-2 AM for mitochondrial calcium

  • Fluo-4 for cytosolic calcium

• Genetic calcium reporters:

  • GCaMP2-mt targeted to mitochondria

  • Can be combined with live cell imaging following stimulation with calcium mobilizing agonists (e.g., histamine 100 μM)

• Electrophysiological approaches:

  • Mitoplast patch clamping to directly measure mitochondrial calcium currents

  • Assess MCU activity in the presence/absence of SLC25A23

• Calcium clearance kinetics:

  • Extended time-course measurements (>1000 seconds) to analyze the role of SLC25A23 in calcium homeostasis

  • Calculating area under the curve for quantitative comparisons

These methodologies collectively provide a comprehensive assessment of how SLC25A23 modulates mitochondrial calcium uptake capacity and kinetics.

How does SLC25A23 influence reactive oxygen species (ROS) generation and oxidative stress responses?

Contrary to initial expectations, SLC25A23 knockdown has been shown to reduce basal mitochondrial ROS levels rather than increase them. This can be examined through:

• Mitochondrial superoxide detection:

  • Using MitoSOX Red, a mitochondrial-targeted superoxide indicator

  • Flow cytometry or confocal microscopy for quantification

• Antioxidant assessment:

  • Measurement of reduced glutathione levels, which increase in SLC25A23 knockdown cells

  • Suggests compensatory antioxidant responses

• Rescue experiments:

  • Reconstitution of SLC25A23 expression in knockdown cells partially restores mitochondrial ROS levels

  • Confirms the specificity of the observed phenotype

• Comparative analysis:

  • Unlike SLC25A23, knockdown of related carriers SLC25A24 and SLC25A25 does not alter mitochondrial ROS levels

  • Indicates a unique role for SLC25A23 in redox regulation

These findings suggest a complex relationship between calcium transport, adenine nucleotide metabolism, and redox homeostasis that warrants further investigation.

What controls should be included when validating SLC25A23 antibody specificity?

To ensure rigorous validation of SLC25A23 antibody specificity, researchers should include:

• Positive controls:

  • Recombinant SLC25A23 protein or overexpression systems

  • Tissues/cells known to express high levels of SLC25A23

• Negative controls:

  • SLC25A23 knockout or knockdown samples

  • Tissues/cells with minimal SLC25A23 expression

• Specificity controls:

  • Cross-reactivity assessment with related family members (SLC25A24, SLC25A25)

  • Peptide competition assays using the immunizing peptide

• Technical controls:

  • Secondary antibody-only controls to assess non-specific binding

  • Loading controls to normalize protein expression

These controls collectively ensure that observed signals genuinely represent SLC25A23 rather than experimental artifacts or cross-reactive proteins.

What are the most common technical challenges when working with SLC25A23 antibodies?

Researchers commonly encounter several technical challenges when working with SLC25A23 antibodies:

• Mitochondrial protein extraction efficiency:

  • SLC25A23's localization in the inner mitochondrial membrane necessitates complete solubilization

  • Standard lysis buffers may be insufficient for complete extraction

• Cross-reactivity with related carriers:

  • The SLC25 family contains structurally similar proteins that may share epitopes

  • Verification with genetic knockdown models is advisable

• Antibody batch variation:

  • Different lots may show varying sensitivity and specificity

  • Batch testing is recommended for longitudinal studies

• Detection sensitivity:

  • Endogenous expression levels may be low in certain cell types

  • Enrichment of mitochondrial fractions may be necessary

• Species cross-reactivity limitations:

  • Many available antibodies are validated only for human samples

  • Careful selection is required for studies in model organisms

Addressing these challenges through appropriate experimental design and controls ensures reliable and reproducible results.

How does SLC25A23 dysfunction contribute to oxidative stress-mediated cell death?

SLC25A23 has been implicated in oxidative stress-mediated cell death through several mechanisms:

• Mitochondrial calcium regulation:

  • SLC25A23 augments mitochondrial calcium uptake through interaction with MCU

  • Excessive mitochondrial calcium can trigger cell death pathways

• Redox homeostasis:

  • SLC25A23 knockdown reduces basal mitochondrial ROS levels

  • Suggests a role in maintaining physiological redox signaling

• Antioxidant systems:

  • Cells with reduced SLC25A23 expression show increased reduced glutathione levels

  • Indicates a shift in cellular redox balance

• Energy metabolism:

  • As an adenine nucleotide transporter, SLC25A23 influences ATP availability

  • May affect cellular responses to metabolic stress

These findings suggest that SLC25A23 sits at a critical intersection of calcium homeostasis, redox signaling, and energy metabolism pathways relevant to cell survival decisions.

What experimental readouts can assess SLC25A23's impact on mitochondrial function?

Multiple experimental parameters can effectively assess SLC25A23's role in mitochondrial function:

• Mitochondrial DNA (mtDNA) copy number:

  • qPCR-based quantification of mitochondrial to nuclear DNA ratio

  • SLC25A23 knockdown does not alter mtDNA copy number

• Oxygen consumption rate (OCR):

  • Respirometry measurements of mitochondrial respiration

  • Provides insights into electron transport chain function

  • SLC25A23 knockdown shows minimal effects on basal OCR

• NAD(P)H levels:

  • Fluorescence-based assessment of reduced nicotinamide nucleotides

  • Indicator of metabolic status

• Calcium dynamics:

  • Both mitochondrial and cytosolic calcium measurements

  • Reveals the role of SLC25A23 in cellular calcium homeostasis

• Reactive oxygen species:

  • MitoSOX for mitochondrial superoxide detection

  • Shows reduced levels in SLC25A23 knockdown cells

The integration of these parameters provides a comprehensive assessment of how SLC25A23 influences mitochondrial physiology beyond its canonical transport function.

What are promising approaches to study the interplay between SLC25A23 and the mitochondrial calcium uniporter complex?

Future research on SLC25A23 and the mitochondrial calcium uniporter complex could benefit from:

• Structural biology approaches:

  • Cryo-electron microscopy to elucidate the structural basis of SLC25A23's interaction with MCU and MICU1

  • Computational modeling of interaction interfaces

• Proximity labeling techniques:

  • BioID or APEX2-based approaches to identify the complete interactome of SLC25A23

  • May reveal additional regulatory partners

• Domain mapping studies:

  • Systematic mutagenesis to identify critical regions for protein-protein interactions

  • Functional assessment of interaction-deficient mutants

• Tissue-specific analyses:

  • Investigation of SLC25A23-MCU interactions in different tissues with varying metabolic demands

  • May reveal context-dependent regulation

• In vivo models:

  • Development of conditional knockout models to assess physiological relevance

  • Tissue-specific phenotyping to uncover specialized functions

These approaches would significantly advance our understanding of how SLC25A23 regulates mitochondrial calcium dynamics in different cellular contexts.

What technologies might improve detection and characterization of SLC25A23 in complex biological samples?

Emerging technologies that could enhance SLC25A23 research include:

• Highly specific monoclonal antibodies:

  • Development of antibodies targeting unique epitopes

  • Validation across multiple applications and species

• Multiplexed protein detection:

  • Mass cytometry (CyTOF) or multiplexed immunofluorescence

  • Simultaneous assessment of SLC25A23 with interacting partners

• Spatial proteomics:

  • Super-resolution microscopy to visualize submitochondrial localization

  • Potential identification of SLC25A23-enriched microdomains

• Proteomics approaches:

  • Targeted mass spectrometry for absolute quantification

  • Post-translational modification mapping

• CRISPR-based endogenous tagging:

  • Knock-in of small epitope tags or fluorescent proteins

  • Enables tracking of endogenous SLC25A23 dynamics

These technological advances would facilitate more precise characterization of SLC25A23's expression, localization, and functional interactions across different experimental systems.